During the past decade, CCOP - Dayton conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 109 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Dayton" #1 sponsor was "SWOG Cancer Research Network" with 78 trials, followed by "Alliance for Clinical Trials in Oncology" with 72 trials sponsored, "Radiation Therapy Oncology Group" with 24 trials sponsored, "National Cancer Institute (NCI)" with 20 trials sponsored and "NSABP Foundation Inc" with 20 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Dayton" #1 collaborator was "National Cancer Institute (NCI)" with 210 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Dayton" are "Breast Cancer" (43 trials), "Lung Cancer" (26 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (21 trials), "Lymphoma" (20 trials) and "Leukemia" (13 trials). Many other conditions were trialed in "CCOP - Dayton" in a lesser frequency.

Most popular intervention types in "CCOP - Dayton" are "Drug" (200 trials), "Biological" (69 trials), "Other" (55 trials), "Radiation" (52 trials) and "Procedure" (41 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (36 trials), "placebo" (29 trials), "cisplatin" (25 trials), "cyclophosphamide" (22 trials) and "paclitaxel" (21 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Dayton" are 188 trials for "All" genders, 42 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Dayton". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 191 completed trials in CCOP - Dayton, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Dayton, 3 "Phase 1" clinical trials were conducted, 128 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".